Literature DB >> 19148787

Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation.

Tetsuya Tanigawa1, Toshio Watanabe, Kazuhide Higuchi, Kazunari Tominaga, Yasuhiro Fujiwara, Nobuhide Oshitani, Andrzej S Tarnawski, Tetsuo Arakawa.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) is associated with chronic gastritis and gastric carcinogenesis. The effects of nonsteroidal anti-inflammatory drugs (NSAIDs), which exert chemopreventive effects on several cancers, on H. pylori-induced gastritis remain unknown. We investigated the effects of NSAIDs on gastric inflammation and the kinetics of gastric epithelial cells in H. pylori-induced gastritis.
METHODS: Patients with rheumatoid arthritis or osteoarthritis who took NSAIDs for more than 1 month and complained of dyspeptic symptoms were recruited for this study. Patients not on any NSAIDs were included as non-NSAID user controls. All patients underwent diagnostic testing for H. pylori infection, esophagogastroduodenoscopy, and gastric biopsies. Neutrophil infiltration into gastric mucosa, expression of inducible nitric oxide synthase (iNOS), and apoptosis and proliferation of gastric epithelial cells were evaluated by immunohistochemistry. In an in vitro study, the effects of NSAIDs on production of interleukin (IL)-8 induced by H. pylori in a gastric epithelial cell line (AGS) were determined.
RESULTS: Numbers of neutrophils infiltrating the gastric mucosa, iNOS-expressing inflammatory cells and apoptotic cells, and proliferating cells in gastric epithelium were higher in H. pylori-positive groups than H. pylori-negative groups. Among H. pyloripositive groups, these parameters were lower in NSAID users than in non-NSAID users. NSAIDs inhibited the production of IL-8 induced by H. pylori in AGS cells.
CONCLUSIONS: These findings suggest that long-term use of NSAIDs normalizes the kinetics of gastric epithelial cells in patients with H. pylori infection by attenuating gastric mucosal inflammation, which may result in prevention of the gastric carcinogenesis associated with H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148787     DOI: 10.1007/s00535-008-2287-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  39 in total

Review 1.  Cyclooxygenase-independent actions of cyclooxygenase inhibitors.

Authors:  I Tegeder; J Pfeilschifter; G Geisslinger
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

2.  The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.

Authors:  M Ohyauchi; A Imatani; M Yonechi; N Asano; A Miura; K Iijima; T Koike; H Sekine; S Ohara; T Shimosegawa
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

4.  Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection: possible involvement of neutrophils through tumor necrosis factor alpha and soluble Fas ligands.

Authors:  J M Kim; J S Kim; H C Jung; I S Song; C Y Kim
Journal:  Scand J Gastroenterol       Date:  2000-01       Impact factor: 2.423

5.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

6.  Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.

Authors:  L Laine; F Cominelli; R Sloane; V Casini-Raggi; M Marin-Sorensen; W M Weinstein
Journal:  Aliment Pharmacol Ther       Date:  1995-04       Impact factor: 8.171

7.  Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.

Authors:  Tetsuya Tanigawa; Toshio Watanabe; Masaki Hamaguchi; Eiji Sasaki; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Takayuki Matsumoto; Kazuhide Higuchi; Tetsuo Arakawa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-09-04       Impact factor: 4.052

8.  Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen.

Authors:  F Brenes; B Ruiz; P Correa; F Hunter; T Rhamakrishnan; E Fontham; T Y Shi
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

9.  Induction of apoptosis in mature T cells by tumour necrosis factor.

Authors:  L Zheng; G Fisher; R E Miller; J Peschon; D H Lynch; M J Lenardo
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

10.  Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.

Authors:  K Akre; A M Ekström; L B Signorello; L E Hansson; O Nyrén
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

View more
  1 in total

Review 1.  Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication.

Authors:  Sang-Ho Park; Napapan Kangwan; Jong-Min Park; Eun-Hee Kim; Ki Baik Hahm
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.